October 9, 2019
Sometimes companies outgrow their brand. For hc1 it was time to slip into a new brand that better reflects the expansion and growth we’ve experienced over the past eight years, as well as the direction we’re now headed.
In 2011, hc1 was born, because our founder believed every patient should be treated as one unique individual. At the outset of the high-value care movement, healthcare organizations focused on increasing value simply by cutting costs, but we knew that sustainable value enhancement could only come from reducing cost by improving outcomes; a goal that could be achieved by tapping into the heartbeat of healthcare – laboratory data.
We believed if labs could organize every individuals’ information intelligently, they could unlock an unprecedented level of clinical decision support to personalize and improve care for all patients. The prediction was right.
Today, the hc1 Platform eliminates waste and personalizes care for more than 1,000 health systems and diagnostic laboratories by turning previously static lab data into actionable healthcare insights. Over the years, the flagship products, hc1 Lab CRM™ and hc1 Test Utilization™, have helped forge a broad set of lab and health system partnerships.
Building on this foundation, in 2018 we introduced a new era of high-value care – precision prescribing – with the invention of hc1 Opioid Advisor™ and hc1 PGx Advisor™, which leverage the hc1 Platform to optimize medications using targeted pharmacogenetics and medication usage analysis.
Today, health systems using the hc1 Platform are able to improve clinical outcomes and reduce medical spend at an unprecedented rate by:
We’re excited to unveil the new brand and look forward to many more years of growth and improving lives with High-Value Care™. Our blog readers are encouraged to browse the new website and get to know more about how they can take advantage of all hc1 is today.